SK Biopharmaceuticals Co., Ltd. (326030.KS)
SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
79,000.00+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-15.8%
The outlook
SK Biopharmaceuticals Co., Ltd. currently reads as neutral based on buy — 1.9 avg of 12 analysts, below its 50- & 200-day averages, 8% of the way from its 52-week low to high, avg target +70% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 12 analysts
Price trendBelow its 50- & 200-day averages
52-week range8% of the way from its 52-week low to high
Price targetAvg target +70% vs current price
Analyst price target
~12-month · 12 analysts134,500.00average target+70.3% vs now
Now 79,000.00
Low 74,000.00High 160,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$6.19T
52-wk high
144,100.00
52-wk low
73,000.00
50-day avg
85,668.00
200-day avg
106,451.00
Trailing P/E
—